BSCI-14. tGLI1 is an actionable therapeutic target in breast cancer brain metastases

Breast cancer is the second leading cause of brain metastases in women; patients with breast cancer brain metastasis (BCBM) survive a median of 14.1 months following diagnosis. Cancer stem cells are thought to be one of the driving forces behind distant metastasis, treatment resistance, and late-sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Doheny, Daniel, Manore, Sara, Wong, Grace, Zhu, Dongqin, Sirkisoon, Sherona, Rimkus, Tadas, Anguelov, Marlyn, Aguayo, Noah, Regua, Angelina, Cox, Anderson O’Brian, Furdui, Cristina, Thomas, Alexandra, Masters, Adrianna Henson, Strowd, Roy, Lo, Hui-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351283/
http://dx.doi.org/10.1093/noajnl/vdab071.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351283/
http://dx.doi.org/10.1093/noajnl/vdab071.013

Ejemplares similares